Absence of cysteine in mice coaxed fat-storing cells to burn energy, causing weight loss and offering potential therapeutic ...

The addition of β-adrenergic receptor antagonists to a medical regimen for heart failure that includes angiotensin-converting enzyme (ACE) inhibitors as background therapy has been associated ...

Notably, the α 2a-adrenergic receptor is expressed in brain regions involved in pain modulation, and α 2a-adrenergic agonists (i.e., drugs that activate this receptor can alleviate chronic and ...

Beta-adrenergic signaling mechanisms are of central importance to cardiovascular health and disease. Modulation of these pathways represents an important pharmacologic approach to the treatment of ...

Adrenergic drugs also interact with these receptors. They can mimic epinephrine and norepinephrine and bind with the receptors, causing the fight or flight responses.

Background: The β2-adrenergic receptor (ADRB2) plays a major role in regulating energy expenditure by stimulating lipid metabolism in human adipose tissue. Polymorphisms in the ADRB2 gene have ...

Alterations in β-adrenergic-receptor signal transduction play a major part in the development of heart failure. Although pharmacologic and device-based therapy can lessen morbidity and mortality ...

Noradrenaline Improves Behavioral Contrast Sensitivity via the β-Adrenergic Receptor. PLOS ONE , 2016; 11 (12): e0168455 DOI: 10.1371/journal.pone.0168455 Cite This Page : ...

Centhaquine (Lyfaquin®) is an adrenergic agent that increases cardiac preload by activating alpha2B adrenergic receptors to increase venous blood return to the heart and decreases cardiac ...

Researchers from Centro Nacional de Investigaciones Cardiovasculares found stimulation of the beta-3 adrenergic receptor in heart cells helps protect and prevent heart failure from aortic ...

APD418 is a first-in-class β3 adrenergic receptor selective antagonist and cardiac myotrope that is expected to improve cardiac contractility with little effect on heart rate, ...